Affinity Capital Advisors, LLC Johnson & Johnson Transaction History

Affinity Capital Advisors, LLC

$515 Million
Q3 2024

A detailed history of Affinity Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Affinity Capital Advisors, LLC holds 2,711 shares of JNJ stock, worth $391,658. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,711

Previous 2,899 6.48%

Holding current value

$391,658

Previous $423,000 3.78%

% of portfolio

0.09%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$145.48 - $167.38 $27,350 - $31,467	-188 Reduced 6.48%	2,711 $439,000
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $30,031 - $32,818	-208 Reduced 6.69%	2,899 $423,000
Q1 2024 Apr 12, 2024	SELL	$155.22 - $162.74 $128,056 - $134,260	-825 Reduced 20.98%	3,107 $491,000
Q4 2023 Jan 11, 2024	SELL	$145.6 - $158.88 $83,574 - $91,197	-574 Reduced 12.74%	3,932 $616,000
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $25,543 - $28,614	-164 Reduced 3.51%	4,506 $701,000
Q2 2023 Jul 13, 2023	BUY	$154.35 - $166.11 $27,937 - $30,065	181 Added 4.03%	4,670 $772,000
Q1 2023 Apr 11, 2023	SELL	$151.05 - $180.26 $45,012 - $53,717	-298 Reduced 6.23%	4,489 $695,000
Q4 2022 Jan 18, 2023	SELL	$160.2 - $179.79 $4,004 - $4,494	-25 Reduced 0.52%	4,787 $0
Q3 2022 Oct 12, 2022	SELL	$161.33 - $179.52 $1,290 - $1,436	-8 Reduced 0.17%	4,812 $786,000
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $1,513 - $1,674	-9 Reduced 0.19%	4,820 $856,000
Q1 2022 Apr 19, 2022	SELL	$158.14 - $179.59 $164,781 - $187,132	-1,042 Reduced 17.75%	4,829 $856,000
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $42,101 - $46,712	270 Added 4.82%	5,871 $1 Million
Q3 2021 Oct 28, 2021	SELL	$161.5 - $179.47 $18,088 - $20,100	-112 Reduced 1.96%	5,601 $905,000
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $797 - $855	-5 Reduced 0.09%	5,713 $941,000
Q1 2021 Apr 19, 2021	BUY	$153.07 - $170.48 $17,909 - $19,946	117 Added 2.09%	5,718 $940,000
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $19,606 - $22,505	-143 Reduced 2.49%	5,601 $881,000
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $28,777 - $31,535	205 Added 3.7%	5,744 $855,000
Q2 2020 Jul 16, 2020	BUY	$128.81 - $155.51 $5,410 - $6,531	42 Added 0.76%	5,539 $779,000
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $53,902 - $74,685	-485 Reduced 8.11%	5,497 $836,000
Q4 2019 Apr 23, 2020	BUY	$127.5 - $146.44 $762,705 - $876,004	5,982 New	5,982 $873,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Capital Advisors, LLC with notifications on news.

Account

Affinity Capital Advisors, LLC Johnson & Johnson Transaction History